Efficacy Comparison between Ertapenem and Flomoxef for Treatment of Hemodialysis Access-Related Bacteremia Secondary to Klebsiella pneumoniae in Critically Ill Hemodialysis Patients
碩士 === 國立中山大學 === 生物科學系研究所 === 102 === Background In the face of increasing treatment options for extended spectrum beta-lactamase (ESBL)-producing Klebsiella pneumonia (ESBL-Kp) hemodialysis (HD) access-related bacteremia, the difference of clinical effectiveness between ertapenem and flomoxef rema...
Main Authors: | Chih-Chao Yang, 楊智超 |
---|---|
Other Authors: | Chung-Lung Cho |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/f2bfss |
Similar Items
-
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing <it>klebsiella pneumoniae</it> in patients on maintenance hemodialysis
by: Yang Chih-Chao, et al.
Published: (2012-09-01) -
Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
by: Lee C, et al.
Published: (2018-02-01) -
Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia
by: Lee CH, et al.
Published: (2018-11-01) -
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy
by: Chih-Chao Yang, et al.
Published: (2014-11-01) -
Successful elimination of hemodialysis-related bacteremia and vascular access infection
by: Jafar Al-Said, et al.
Published: (2013-01-01)